Yahoo
ASX - Delayed Quote AUD

Paradigm Biopharmaceuticals Limited (PAR.AX)

0.2450 0.0000 (0.00%)
At close: September 18 at 4:10:25 PM GMT+10
View in AlphaSpace Currency in AUD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
6/30/2026
6/30/2025
6/30/2024
6/30/2023
Total Revenue
80.1500
80.1500
--
65.8000
46.7600
Cost of Revenue
12.1280
12.1280
--
8.9880
18.8270
Gross Profit
68.0220
68.0220
--
56.8120
27.9330
Operating Expense
61,329.9550
61,329.9550
--
65,249.9300
60,066.4400
Operating Income
-61,261.9330
-61,261.9330
--
-65,193.1180
-60,038.5070
Net Non Operating Interest Income Expense
-2,041.7500
-2,041.7500
--
392.6440
1,386.1610
Other Income Expense
6,822.0490
6,822.0490
--
6,000.5500
6,742.3330
Pretax Income
-56,331.2460
-56,331.2460
--
-58,653.1880
-51,910.0130
Tax Provision
0
0
--
0
0
Net Income Common Stockholders
-56,331.2460
-56,331.2460
--
-58,653.1880
-51,910.0130
Basic EPS
-0.15
-0.15
-0.06
-0.20
-0.18
Diluted EPS
-0.15
-0.15
-0.06
-0.20
-0.18
Basic Average Shares
370,033.4860
370,033.4860
314,501.1240
293,283.5170
289,678.3530
Diluted Average Shares
370,033.4860
370,033.4860
314,501.1240
293,283.5170
289,678.3530
Net Income from Continuing & Discontinued Operation
-56,331.2460
-56,331.2460
--
-58,653.1880
-51,910.0130
Normalized Income
-56,331.2460
-56,331.2460
--
-58,653.1880
-51,910.0130
Interest Income
419.1330
419.1330
--
407.0140
1,402.5770
Interest Expense
2,460.8830
2,460.8830
--
14.3700
16.4160
Net Interest Income
-2,041.7500
-2,041.7500
--
392.6440
1,386.1610
EBIT
-53,870.3630
-53,870.3630
--
-58,638.8180
-51,893.5970
EBITDA
-53,719.9750
-53,719.9750
--
-58,492.0820
-51,893.5970
Reconciled Cost of Revenue
12.1280
12.1280
--
8.9880
18.8270
Reconciled Depreciation
150.3880
150.3880
--
146.7360
--
Net Income from Continuing Operation Net Minority Interest
-56,331.2460
-56,331.2460
--
-58,653.1880
-51,910.0130
Normalized EBITDA
-53,719.9750
-53,719.9750
--
-58,492.0820
-51,893.5970
Tax Rate for Calcs
0
0
--
0
0
Tax Effect of Unusual Items
0
0
--
0
0
6/30/2023 - 8/19/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: